跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 139 条关于
“Xbrick”
全部
139
临床试验
105
药物
14
机构
3
资讯
17
去年
Samsung Bioepis Receives Positive CHMP Opinion for Denosumab Biosimilars Ovodence and Xbrick
去年
Brisk Walking Significantly Reduces Risk of Heart Rhythm Disorders, New Study Finds
去年
Samsung Bioepis Receives Positive EMA Opinion for Denosumab Biosimilars Obodence and Xbryk
去年
Samsung Bioepis Receives Positive CHMP Opinion for Denosumab Biosimilars OBODENCE and XBRYK
去年
MANIFEST Project Aims to Personalize Immunotherapy Through Biomarker Analysis
10个月前
Breakthrough in Remote Alzheimer's Testing: Finger-Prick Blood Samples Enable Global Disease Detection
去年
Samsung Bioepis Secures Korean Approval for Denosumab Biosimilar XBRYK, Completing Global Regulatory Trifecta
3个月前
Cancer's MHC I Evasion Trick Backfires: CD4+ T Cells Unleash Ferroptosis Against Tumors
去年
Brisk Walking Shows Significant Health Benefits in Large-Scale Studies of Older Adults
3个月前
Five-Minute Finger-Prick Syphilis Test Aims to Protect Newborns from Congenital Infection
第 1 页,共 2 页
上一页
下一页